Overview

Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Oral anticoagulation is often initiated in hospitalized patients. Although the therapeutic range of phenprocoumon is narrow, the individual drug demands unfortunately vary greatly between persons. Our group recently developed two dosing algorithms for the initiation of anticoagulation based on clinical predictors such as age, gender, body weight and laboratory values. The aim of the proposed study is to prospectively evaluate the efficacy and safety of these two algorithms in medical and orthopedic inpatients, as well as in a group of outpatients and possibly in a geriatric collective.
Phase:
Phase 4
Details
Lead Sponsor:
Cantonal Hospital of St. Gallen
Treatments:
Phenprocoumon